surmount-1 trial tirzepatide obesity without diabetes for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 A 3-year study of tirzepatide
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15










01127-3/asset/36c2a416-592c-4382-987a-90ca08fb616f/main.assets/gr3.jpg)





31271-1/asset/3ba32ab6-9a1d-4c0e-ba7f-294eac127f1e/main.assets/gr3_lrg.jpg)




30192-5/asset/750b1b24-dd0f-4217-b391-8b32512cb4e2/main.assets/gr3_lrg.jpg)





